Register entry

Iovance Biotherapeutics, Inc.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Labeller names
2
Live patents
0
Countries
1
Base
United States
Authorisation

Registered operations

Analytical testing1Finished drug manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Iovance Biotherapeutics Manufacturing LLCRegistrant: Iovance Biotherapeutics, Inc.300 Rouse Blvd, Philadelphia, Pennsylvania (PA) 19112, United States (USA)Analytical testing, Finished drug manufacture3020882632118423955
Catalogue

Drug listings by form and route

2

2 active NDC listings: 1 cellular therapy, 1 human prescription drug. By marketing category: BLA 2.

Dosage formNDCs
injection, powder, lyophilized, for solution1
suspension1
RouteNDCs
intravenous2
Labeller name on the listingNDCs
iovance biotherapeutics inc.1
iovance biotherapeutics, inc1
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
AMTAGVIlifileucelsuspension, intravenous73776-001BLA
PROLEUKINaldesleukininjection, powder, lyophilized, for solution, intravenous73776-022BLA
Neighbours

Registered in the same town

8
Compare

Comparable companies in United States

Enquiry

Common questions

Is Iovance Biotherapeutics, Inc. FDA approved?
Iovance Biotherapeutics, Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Iovance Biotherapeutics, Inc.'s drugs manufactured?
The FDA register lists Philadelphia, PA. Registered operations: analytical testing, finished drug manufacture.
What drugs does Iovance Biotherapeutics, Inc. make?
2 products are listed under Iovance Biotherapeutics, Inc. in the openFDA NDC Directory, most often as injection, powder, lyophilized, for solution; suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.